Views & Analysis Pandemic boost to decentralised trials is here to stay Due to the pandemic, decentralised trial solutions made the shift from an emerging trend to a crucial element of drug development.
Partner Content Partner Content Making the most of your remaining communications budget pharmaphorum connect's Mark Walmsley describes seven projects to maximise remaining communications budgets.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face